This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Financial Reporting Remove Pharmaceutical Remove Risk Management Related Topics
IFRS Financial Modeling Financial Analysis Financial Planning and Analysis (FP&A) Data Analysis SAP Auditing Treasury Invoicing Leadership More Related Topics >
article thumbnail

TNFD Releases Final Recommendations on Nature-Related Risk Management

Future CFO

SEPTEMBER 19, 2023

The Taskforce on Nature-related Financial Disclosures on Sept. 18 released its final recommendations on nature-related risk management and disclosure, aligned with existing Global Reporting Initiative (GRI) and International Financial Reporting Standards (IFRS) and Kunming-Montreal Biodiversity Framework requirements.

Risk Management 52
Risk Management IFRS Pharmaceutical Economics 52
article thumbnail

5 Excel-heavy Pain Points still Dragging down finance teams in 2024

The Finance Weekly

JANUARY 21, 2024

A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One workaround found in cumbersome financial reporting processes includes using old legacy Excel-based financial models.

Financial Planning and Analysis (FP&A) 40
Financial Planning and Analysis (FP&A) Finance Data Analysis Financial Modeling 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 68,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
LinkedIn Twitter
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024